Doctor Explains Link Between Obesity and Type 2 Diabetes Risk
Translated from Indonesian, summarized and contextualized by DistantNews.
At a glance
- Excessive fat accumulation, especially around the abdomen, can trigger insulin resistance, a key factor in Type 2 diabetes development, according to Prof. Sidartawan Soegondo.
- Obesity is not just about weight but increases the risk of serious metabolic diseases like Type 2 diabetes, as the pancreas must overproduce insulin.
- Lifestyle changes are crucial for managing obesity, but medication and newer therapies like GLP-1 receptor agonists can also aid in weight management and blood sugar control for patients with Type 2 diabetes.
Obesity is more than just a weight or body shape issue; it significantly elevates the risk of serious metabolic diseases, including Type 2 diabetes. Prof. Sidartawan Soegondo, a consultant in endocrinology, metabolism, and diabetes, explained that excess fat, particularly in the abdominal area, can lead to insulin resistance. This condition impairs the body's response to insulin, a hormone essential for regulating blood sugar.
When individuals are obese, their body tissues become less responsive to insulin. The pancreas compensates by producing more insulin to maintain normal blood glucose levels. However, over prolonged periods, this sustained effort can deplete the pancreas's capacity, and the reduced effectiveness of insulin further contributes to rising blood sugar, ultimately paving the way for Type 2 diabetes.
Addressing obesity fundamentally requires lifestyle modifications, primarily through dietary adjustments and increased physical activity. For some patients, however, consistent lifestyle changes may not yield optimal weight loss. In such cases, medical intervention might be considered by doctors, especially for those with co-existing conditions like Type 2 diabetes, hypertension, or high cholesterol.
Medication should be prescribed based on medical indications and under a doctor's supervision, serving as a complement to, not a replacement for, a healthy lifestyle. Encouragingly, recent advancements in diabetes therapy offer treatment options that not only manage blood sugar but also assist with weight management. Therapies such as GLP-1 receptor agonists and dual incretin treatments can help patients feel fuller, slow stomach emptying, reduce appetite, and improve blood sugar control, offering a dual benefit for obese individuals with Type 2 diabetes.
Originally published by Republika in Indonesian. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.